Table 1.
Patient characteristics
| Parameter | All patients (%) | Patients with IR (%) | Patients with AR (%) |
|---|---|---|---|
| Total | 50 | 28 | 22 |
| Sex | |||
| Female | 18 (36) | 12 (43) | 6 (27) |
| Male | 32 (64) | 16 (57) | 16 (73) |
| Stage | |||
| I | 1 (2) | 0 | 1 (5) |
| II | 26 (52) | 16 (57) | 10 (45) |
| III | 7 (14) | 2 (7) | 5 (23) |
| IV | 16 (32) | 10 (36) | 6 (27) |
| TG/TL | |||
| 1 | 12 (24) | 6 (21) | 6 (27) |
| 2 | 17 (34) | 10 (36) | 7 (32) |
| 3 | 21 (42) | 12 (43) | 9 (41) |
| ESR ≥ 30 mm/h | |||
| Yes | 33 (66) | 19 (68) | 14 (64) |
| No | 17 (34) | 9 (32) | 8 (36) |
| Bulk ≥ 200 ml | |||
| Yes | 17 (34) | 12 (43) | 5 (23) |
| No | 33 (66) | 16 (57) | 17 (77) |
| B-symptoms | |||
| Yes | 23 (46) | 12 (43) | 11 (50) |
| No | 27 (54) | 16 (57) | 11 (50) |
| Extranodal | |||
| Yes | 8 (16) | 4 (14) | 4 (18) |
| No | 42 (84) | 24 (86) | 18 (82) |
| Protocol | |||
| PHL-C1 | 42 (84) | 25 (89) | 17 (77) |
| PHL-C2 | 8 (16) | 3 (11) | 5 (23) |
IR inadequate response, AR adequate response, TG/TL treatment group/level, ESR erythrocyte sedimentation rate